Clinical trial
Initial Feasibility Study of SelfWrap-Assisted Arteriovenous Fistulas (SW-AVF)
NCT05418816 is registered in ClinicalTrials.gov with VenoStent as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Initial Feasibility Study of SelfWrap-Assisted Arteriovenous Fistulas (SW-AVF)
- Lead sponsor
- VenoStent
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- June 14, 2021
- Completion date
- September 30, 2026
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arteriovenous fistula, arteriovenous malformations, catheter complications, catheter dysfunction, chronic kidney diseases, chronic kidney failure, end stage kidney disease, end stage renal disease, fistula, hemodialysis access failure, renal failure, renal failure chronic, renal insufficiency, urologic diseases, vascular diseases, vascular fistula, vascular malformations